• Return to Headlines

Shares of ESPR Down 19.9% Since Downtrend Call on Shares

By James Quinn

SmarTrend identified a Downtrend for Esperion Therape (NASDAQ:ESPR) on July 1st, 2019 at $45.89. In approximately 2 months, Esperion Therape has returned 19.94% as of today's recent price of $36.74.

In the past 52 weeks, Esperion Therape share prices have been bracketed by a low of $33.13 and a high of $60.99 and are now at $36.84, 11% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has declined 2.7%.

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Esperion Therape.

Log in and add Esperion Therape (ESPR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights esperion therape

Ticker(s): ESPR